SetPoint Medical
- Total Funding$84.3 M
OverviewSuggest Edit
SetPoint Medical is a biomedical technology company developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis and Crohn's Disease.
The company's scientific platform is based on the Inflammatory Reflex—the natural mechanism by which the central nervous system regulates the immune system. SetPoint's approach uses vagus nerve stimulation to activate the Inflammatory Reflex, which published literature suggests produces a potent systemic anti-inflammatory effect. The Company's novel platform consists of an implantable miniature neuromodulation device, wireless charger, and iPad control application.
| Type | Private | |
| Founded | 2006 | |
| HQ | Santa Clarita, CA, US | Map |
| Website | setpointmedical.com | |
| Employee Ratings | ||
| Overall Culture | A | More |
Recent NewsAll News
- SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
- Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical
- SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
- SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
Latest Updates
| Employees (est.) (Apr 2022) | 57 | (-1%) |
| Cybersecurity rating | A | More |
Key People/Management at SetPoint Medical
Murthy Simhambhatla
CEO
David Chernoff
Chief Medical Officer
Bill Calle
VP of Product Development
Lusin Markaryan
VP of Regulatory Affairs
Ankit Shah
Senior Director of Commercialization and Marketing
Kevin Wilkin
Director of Quality
SetPoint Medical Office Locations
SetPoint Medical has an office in Santa Clarita
Santa Clarita, CA, US (HQ)
25101 Rye Canyon Loop
SetPoint Medical Financials and Metrics
Summary Metrics
Founding Date | 2006 |
SetPoint Medical total Funding | $84.3 m |
SetPoint Medical latest funding size | $30 m |
Time since last funding | 5 years ago |
SetPoint Medical investors | New Enterprise Associates, Morgenthaler Ventures, Medtronic, Topspin Partners, Boston Scientific, Covidien Ventures, Action Potential Venture Capital, Flare Capital Partners, GSK (GlaxoSmithKline), Abbott |
SetPoint Medical's latest funding round in August 2017 was reported to be $30 m. In total, SetPoint Medical has raised $84.3 m
SetPoint Medical Cybersecurity Score
SetPoint Medical Online and Social Media Presence
301 Twitter followers
SetPoint Medical has 301 Twitter Followers. The number of followers has increased 0.4% month over month and increased 2.8% quarter over quarter
SetPoint Medical's Trends
SetPoint Medical Company Culture
Overall Culture
A
90/100
CEO Rating
A+
90/100
Compensation
A+
100/100
SetPoint Medical News and Updates
November 03, 2021
SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
Accomplished leader will advance SetPoint's clinical program in rheumatoid arthritis Accomplished leader will advance SetPoint's clinical program in rheumatoid arthritis
July 13, 2021
Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical
WOODSIDE, Calif., July 13, 2021 /PRNewswire/ -- Runway Growth Capital LLC ("Runway"), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a senior secured term loan of $35 million to...
March 03, 2021
SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
VALENCIA, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the American Institute for Biological and Medical Engineering (AIMBE) has elected Murthy Simhambhatla, PhD…
February 01, 2021
SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
Pivotal IDE Study will evalute SetPoint’s propriertary bioelectronic device for treatment of Rheumatoid Arthritis Pivotal IDE Study will evalute SetPoint’s propriertary bioelectronic device for treatment of Rheumatoid Arthritis
January 27, 2021
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA). The company is developing its platform for the treatment of chronic, inflam…
October 06, 2020
SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform
VALENCIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the use of its novel bioelectronic device for patients with rheumatoid arthritis (RA) who have incomp…
SetPoint Medical Blogs
April 06, 2022
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study
The inflammatory reflex plays a role in regulating innate and adaptive immunity by modulating cellular and molecular inflammatory pathways. The vagus nerve is a major constituent of the inflammatory reflex and studies have shown that the reflex can be activated by electrical stimulation of the vagus…
January 27, 2022
New technology could signal the future of medicine
ABC News’ Will Carr reports on new, cutting-edge bioelectronic medicine that holds promise for treating diseases like Crohn’s and Parkinson’s.
The post New technology could signal the future of medicine appeared first on SetPoint Medical.
August 13, 2018
SetPoint Medical Appoints Murthy Simhambhatla as President and Chief Executive Officer
Industry veteran brings biopharma and medical device company leadership experience as SetPoint advances its proprietary bioelectronic medicine platform Valencia, CA – August 13, 2018 – SetPoint Medical, a clinical-stage company developing bioelectronic therapy for chronic inflammatory diseases, an…
June 19, 2018
SetPoint Medical Reports Positive Long-term Results from its Clinical Study of Bioelectronic Medicine to Treat Rheumatoid Arthritis
Results presented at Annual European Congress of Rheumatology highlight strong therapy adherence and significant reduction in rheumatoid arthritis symptoms after 24-months of therapy Valencia, CA – June 19, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing bioelect…
June 11, 2018
SetPoint Medical Presents Positive Data from its Clinical Study of Bioelectronic Medicine for Treatment of Crohn’s Disease
Proof-of-Concept Data Presented at Digestive Disease Week in Washington D.C. Valencia, CA – June 11, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced the presentation of positive clinical results …
SetPoint Medical Frequently Asked Questions
When was SetPoint Medical founded?
SetPoint Medical was founded in 2006.
Who are SetPoint Medical key executives?
SetPoint Medical's key executives are Murthy Simhambhatla, David Chernoff and Bill Calle.
How many employees does SetPoint Medical have?
SetPoint Medical has 57 employees.
Who are SetPoint Medical competitors?
Competitors of SetPoint Medical include Tivic Health, Inspire Medical Systems and Restorative Therapies.
Where is SetPoint Medical headquarters?
SetPoint Medical headquarters is located at 25101 Rye Canyon Loop, Santa Clarita.
Where are SetPoint Medical offices?
SetPoint Medical has an office in Santa Clarita.
How many offices does SetPoint Medical have?
SetPoint Medical has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies